Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions

Infection and Immunity

Volumn 78, Issue 6, 2010, Pages 2438-2445

  Abu Dayyeh, Issa ^a,b   Hassani, Kasra ^a,b   Westra, Edze R ^a,c   Mottram, Jeremy C ^d   Olivier, Martin ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; GAMMA INTERFERON; I KAPPA B; LMCPB PROTEIN; NITRIC OXIDE; PROTEIN; PROTEIN P35; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; SPHINGOLIPID ACTIVATOR PROTEIN 1; STAT1 PROTEIN; STAT1ALPHA PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

AMASTIGOTE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; LEISHMANIA MEXICANA; MACROPHAGE; MACROPHAGE FUNCTION; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTOZOAL INFECTION;

ANIMALS; CELL LINE; CYSTEINE PROTEASES; HUMANS; INTERFERON-GAMMA; INTERFERON-STIMULATED GENE FACTOR 3; LEISHMANIA MEXICANA; MACROPHAGES; MICE; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTOZOAN PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA;

EID: 77952685682     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00812-09     Document Type: Article

References (44)

1. Abu-Dayyeh, I., M. T. Shio, S. Sato, S. Akira, B. Cousineau, and M. Olivier. 2008. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLoS Negl. Trop. Dis. 2:e305.
2. Alexander, J., G. H. Coombs, and J. C. Mottram. 1998. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol. 161:6794-6801.
3. Blackwell, J. M., R. A. B. Ezekowitz, M. B. Roberts, J. Y. Channon, R. B. Sim, and S. Gordon. 1985. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 162:324-331.
4. Blanchette, J., I. Abu-Dayyeh, K. Hassani, L. Whitcombe, and M. Olivier. 2009. Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1). Immunology 127:123-133.
5. Blanchette, J., N. Racette, R. Faure, K. A. Siminovitch, and M. Olivier. 1999. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur. J. Immunol. 29:3737-3744.
6. Brittingham, A., G. Chen, B. S. McGwire, K. P. Chang, and D. M. Mosser. 1999. Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect. Immun. 67:4477-4484.
7. Cameron, P., A. McGachy, M. Anderson, A. Paul, G. H. Coombs, J. C. Mottram, J. Alexander, and R. Plevin. 2004. Inhibition of lipopolysaccharide- induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-κB signaling pathway. J. Immunol. 173:3297-3304.
8. Choi, C. M., and E. A. Lerner. 2001. Leishmaniasis as an emerging infection. J. Investig. Dermatol. Symp. Proc. 6:175-182.
9. Culley, F. J., R. A. Harris, P. M. Kaye, K. McAdam, and J. G. Raynes. 1996. C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J. Immunol. 156:4691-4696.
10. Ferguson, M. A. 1997. The surface glycoconjugates of trypanosomatid parasites. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352:1295-1302.
11. Forget, G., D. J. Gregory, and M. Olivier. 2005. Proteasome-mediated degradation of STAT1 alpha following infection of macrophages with Leishmania donovani. J. Biol. Chem. 280:30542-30549.
12. Forget, G., D. J. Gregory, L. A. Whitcombe, and M. Olivier. 2006. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect. Immun. 74:6272-6279.
13. Forget, G., C. Matte, K. A. Siminovitch, S. Rivest, P. Pouliot, and M. Olivier. 2005. Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1. Eur. J. Immunol. 35:1906-1917.
14. Forget, G., K. A. Siminovitch, S. Brochu, S. Rivest, D. Radzioch, and M. Olivier. 2001. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol. 31:3185-3196.
15. Gomez, M. A., I. Contreras, M. Halle, M. L. Tremblay, R. W. McMaster, and M. Olivier. 2009. Leishmania GP63 alters host signaling through cleavageactivated protein tyrosine phosphatases. Sci. Signal. 2:ra58.
16. Gregory, D. J., M. Godbout, I. Contreras, G. Forget, and M. Olivier. 2008. A novel form of NF-kappa B is induced by Leishmania infection: involvement in macrophage gene expression. Eur. J. Immunol. 38:1071-1081.
17. Jaramillo, M., and M. Olivier. 2002. Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase and cyclic adenosine 5′-monophosphate (cAMP)-dependent pathways: involvement of NF-kappa B, activator protein 1, and cAMP response element binding protein. J. Immunol. 169:7026-7038. (Pubitemid 36899290)
18. Kane, M. M., and D. M. Mosser. 2000. Leishmania parasites and their ploys to disrupt macrophage activation. Curr. Opin. Hematol. 7:26-31.
19. Lowenstein, C. J., E. W. Alley, P. Raval, A. M. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon-gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 90:9730-9734.
20. Markova, B., P. Gulati, P. A. Herlich, and F. D. Bohmer. 2005. Investigation of protein-tyrosine phosphatases by in-gel assays. Methods 35:22-27. (Pubitemid 39647575)
21. McConville, M. J., and J. M. Blackwell. 1991. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani: characterization of the promastigote and amastigote glycolipids. J. Biol. Chem. 266:15170-15179.
22. Medina-Acosta, E., R. E. Karess, H. Schwartz, and D. G. Russell. 1989. The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage. Mol. Biochem. Parasitol. 37:263-273.
23. Melby, P. C. 2002. Recent developments in leishmaniasis. Curr. Opin. Infect. Dis. 15:485-490.
24. Melby, P. C., B. Chandrasekar, W. G. Zhao, and J. E. Coe. 2001. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J. Immunol. 166:1912-1920.
25. Morton, S., R. J. Davis, A. McLaren, and P. Cohen. 2003. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 22:3876-3886. (Pubitemid 36975714)
26. Mottram, J. C., G. H. Coombs, and J. Alexander. 2004. Cysteine peptidases as virulence factors of Leishmania. Curr. Opin. Microbiol. 7:375-381.
27. Mottram, J. C., A. E. Souza, J. E. Hutchison, R. Carter, M. J. Frame, and G. H. Coombs. 1996. Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc. Natl. Acad. Sci. U. S. A. 93:6008-6013.
28. Myers, M. P., J. N. Andersen, A. Cheng, M. L. Tremblay, C. M. Horvath, J.-P. Parisien, A. Salmeen, D. Barford, and N. K. Tonks. 2001. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276:47771-47774.
29. Nandan, D., R. Lo, and N. E. Reiner. 1999. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67:4055-4063. (Pubitemid 29357028)
30. Nandan, D., T. L. Yi, M. Lopez, C. Lai, and N. E. Reiner. 2002. Leishmania EF-1 alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J. Biol. Chem. 277: 50190-50197.
31. Olivier, M., D. J. Gregory, and G. Forget. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18:293-305.
32. Olivier, M., B. J. Romero-Gallo, C. Matte, J. Blanchette, B. I. Posner, M. J. Tremblay, and R. Faure. 1998. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition: effect on murine leishmaniasis progression. J. Biol. Chem. 273:13944-13949.
33. Pimenta, P. F. P., E. M. B. Saraiva, and D. L. Sacks. 1991. The comparative fine structure and surface glycoconjugate expression of three life stages of Leishmania major. Exp. Parasitol. 72:191-204.
34. Pollock, K. G. J., K. S. McNeil, J. C. Mottram, R. E. Lyons, J. M. Brewer, P. Scott, G. H. Coombs, and J. Alexander. 2003. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J. Immunol. 170: 1746-1753.
35. Proudfoot, L., A. V. Nikolaev, G. J. Feng, X. Q. Wei, M. A. J. Ferguson, J. S. Brimacombe, and F. Y. Liew. 1996. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. U. S. A. 93:10984-10989.
36. Proudfoot, L., C. A. Odonnell, and F. Y. Liew. 1995. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur. J. Immunol. 25:745-750.
37. Radzioch, D., T. Hudson, M. Boule, L. Barrera, J. W. Urbance, L. Varesio, and E. Skamene. 1991. Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J. Leukoc. Biol. 50:263-272.
38. Schneider, P., J. P. Rosat, J. Bouvier, J. Louis, and C. Bordier. 1992. Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages. Exp. Parasitol. 75:196-206.
39. Souza, A. E., S. Waugh, G. H. Coombs, and J. C. Mottram. 1992. Characterization of a multicopy gene for a major stage-specific cysteine proteinase of Leishmania mexicana. FEBS Lett. 311:124-127.
40. Talamas-Rohana, P., S. D. Wright, M. R. Lennartz, and D. G. Russell. 1990. Lipophosphoglycan from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and LFA-1 family of leukocyte integrins. J. Immunol. 144:4817-4824.
41. Wanderley, J. L. M., M. E. C. Moreira, A. Benjamin, A. C. Bonomo, and M. A. Barcinski. 2006. Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts. J. Immunol. 176:1834-1839.
42. Xie, Q. W., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-gamma and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
43. Xu, H. M., H. Z. An, J. Hou, C. F. Han, P. Wang, Y. Z. Yu, and X. T. Cao. 2008. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages. Mol. Immunol. 45:3545-3552.
44. Zhu, X., Z. Wen, L. Z. Xu, and J. E. Darnell, Jr. 1997. Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol. Cell. Biol. 17:6618-6623.